VIVESTO ABVIVESTO ABVIVESTO AB

VIVESTO AB

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪147.42 M‬SEK
−0.2190SEK
‪−128.74 M‬SEK
‪537.93 M‬
Beta (1Y)
−0.60

About VIVESTO AB

CEO
Erik Kinnman
Headquarters
Solna
Website
Employees (FY)
14
Founded
1988
ISIN
SE0000722365
FIGI
BBG000QWP8S5
Vivesto AB engages in the research and development of drugs. It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. The company was founded by Julian Aleksov and Bo Cederstrand in 1999 and is headquartered in Solna, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of VIVE is 0.2740 SEK — it has increased by 2.05% in the past 24 hours. Watch VIVESTO AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange VIVESTO AB stocks are traded under the ticker VIVE.
VIVE stock has risen by 4.58% compared to the previous week, the month change is a 10.89% fall, over the last year VIVESTO AB has showed a 4.03% decrease.
VIVE reached its all-time high on Feb 19, 2014 with the price of 22.2560 SEK, and its all-time low was 0.1615 SEK and was reached on Dec 1, 2023. View more price dynamics on VIVE chart.
See other stocks reaching their highest and lowest prices.
VIVE stock is 5.38% volatile and has beta coefficient of −0.60. Track VIVESTO AB stock price on the chart and check out the list of the most volatile stocks — is VIVESTO AB there?
Today VIVESTO AB has the market capitalization of ‪147.42 M‬, it has decreased by 1.12% over the last week.
Yes, you can track VIVESTO AB financials in yearly and quarterly reports right on TradingView.
VIVESTO AB is going to release the next earnings report on Aug 22, 2024. Keep track of upcoming events with our Earnings Calendar.
VIVE net income for the last quarter is ‪−8.42 M‬ SEK, while the quarter before that showed ‪−64.36 M‬ SEK of net income which accounts for 86.92% change. Track more VIVESTO AB financial stats to get the full picture.
No, VIVE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 14, 2024, the company has 14.00 employees. See our rating of the largest employees — is VIVESTO AB on this list?
Like other stocks, VIVE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VIVESTO AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VIVESTO AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VIVESTO AB stock shows the strong sell signal. See more of VIVESTO AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.